Pfizer reported FY2025 revenue of $62.6 billion and Q1 2026 revenue of $14.5 billion. The thesis depends on portfolio durability, oncology integration, patent cliffs, operating cash flow, debt capacity and pipeline execution.
References
Sources used in this report
SEC datasetSEC company tickers exchange datasetRetrieved 2026-05-20 · Issuer identity, ticker, exchange and CIKSEC APISEC submissions APIRetrieved 2026-05-20 · Filing chronology and company identitySEC XBRL APISEC companyfacts APIRetrieved 2026-05-20 · Financial statement cross-checksAnnual reportFY2025 Form 10-K filed 2026-02-262026 · Annual business, risk and financial baselineQuarterly reportForm 10-Q filed 2026-05-052026 · Latest interim financial baselineCurrent reportForm 8-K filed 2026-05-052026 · Recent filing chronologyProxy statementDEF 14A filed 2026-03-122026 · Governance and incentive context